Literature DB >> 8227337

Protamine-mediated transport of albumin into brain and other organs of the rat. Binding and endocytosis of protamine-albumin complex by microvascular endothelium.

W M Pardridge1, J L Buciak, Y S Kang, R J Boado.   

Abstract

High doses of intravenous protamine cause generalized vascular permeability changes in brain and other organs, and concomitant hypoproteinemia. The present investigations test the hypothesis that protamine has a dual action of both binding serum proteins and of undergoing absorptive-mediated transcytosis through microvascular endothelial barriers. Binding of albumin to protamine was demonstrated using equilibrium dialysis, and protamine was shown to selectively augment the uptake of albumin, but not sucrose, in isolated bovine or human brain capillaries. In contrast, the anionic macromolecule, dextran sulfate, resulted in an increased capillary uptake of both albumin and sucrose in vitro. The selective effects of protamine on albumin transport were also documented in vivo using an external organ technique; the intravenous injection of 1.5 mg/kg protamine resulted in a marked and selective influx of albumin into brain, heart, kidney, lung, and liver, and the increased albumin transport exceeded the increased sucrose uptake in some organs by an order of magnitude. The transcytosis of protamine through the cerebral microvascular barrier was documented with an internal carotid artery perfusion technique. In summary, these studies provide evidence for protamine-mediated vectorial transport of albumin through microvascular barriers in brain and other organs.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8227337      PMCID: PMC288402          DOI: 10.1172/JCI116825

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  21 in total

1.  Nucleotide sequence of a bovine protamine cDNA.

Authors:  C H Lee; A Mansouri; W Hecht; N B Hecht; W Engel
Journal:  Biol Chem Hoppe Seyler       Date:  1987-02

2.  Absence of albumin receptor on brain capillaries in vivo or in vitro.

Authors:  W M Pardridge; J Eisenberg; W T Cefalu
Journal:  Am J Physiol       Date:  1985-09

3.  Blood-brain barrier transport of cationized immunoglobulin G: enhanced delivery compared to native protein.

Authors:  D Triguero; J B Buciak; J Yang; W M Pardridge
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

4.  Ultracytochemical characterization of anionic sites in the wall of brain capillaries.

Authors:  A W Vorbrodt
Journal:  J Neurocytol       Date:  1989-06

5.  Frequency and specificity of protamine antibodies in diabetic and control subjects.

Authors:  L J Nell; J W Thomas
Journal:  Diabetes       Date:  1988-02       Impact factor: 9.461

6.  Absorptive-mediated endocytosis of cationized albumin and a beta-endorphin-cationized albumin chimeric peptide by isolated brain capillaries. Model system of blood-brain barrier transport.

Authors:  A K Kumagai; J B Eisenberg; W M Pardridge
Journal:  J Biol Chem       Date:  1987-11-05       Impact factor: 5.157

7.  Tracer kinetic model of blood-brain barrier transport of plasma protein-bound ligands. Empiric testing of the free hormone hypothesis.

Authors:  W M Pardridge; E M Landaw
Journal:  J Clin Invest       Date:  1984-09       Impact factor: 14.808

8.  Transport of histone through the blood-brain barrier.

Authors:  W M Pardridge; D Triguero; J Buciak
Journal:  J Pharmacol Exp Ther       Date:  1989-12       Impact factor: 4.030

9.  Intracarotid infusions of protamine sulfate disrupt the blood-brain barrier of rabbits.

Authors:  L J Strausbaugh
Journal:  Brain Res       Date:  1987-04-21       Impact factor: 3.252

10.  Association of protamine IgE and IgG antibodies with life-threatening reactions to intravenous protamine.

Authors:  M E Weiss; D Nyhan; Z K Peng; J C Horrow; E Lowenstein; C Hirshman; N F Adkinson
Journal:  N Engl J Med       Date:  1989-04-06       Impact factor: 91.245

View more
  12 in total

1.  Engineered nanoparticles for systemic siRNA delivery to malignant brain tumours.

Authors:  Johan Karlsson; Yuan Rui; Kristen L Kozielski; Amanda L Placone; Olivia Choi; Stephany Y Tzeng; Jayoung Kim; Jamal J Keyes; Max I Bogorad; Kathleen Gabrielson; Hugo Guerrero-Cazares; Alfredo Quiñones-Hinojosa; Peter C Searson; Jordan J Green
Journal:  Nanoscale       Date:  2019-10-15       Impact factor: 7.790

2.  Isolation and molecular characterization of brain microvascular endothelial cells from human brain tumors.

Authors:  Ronald E Unger; Jens B Oltrogge; Hagen von Briesen; Britta Engelhardt; Ulrike Woelki; Wolfgang Schlote; Rudiger Lorenz; Hansjurgen Bratzke; C James Kirkpatrick
Journal:  In Vitro Cell Dev Biol Anim       Date:  2002-05       Impact factor: 2.416

3.  Effective intravenous therapy for neurodegenerative disease with a therapeutic enzyme and a peptide that mediates delivery to the brain.

Authors:  Yu Meng; Istvan Sohar; David E Sleat; Jason R Richardson; Kenneth R Reuhl; Robert B Jenkins; Gobinda Sarkar; Peter Lobel
Journal:  Mol Ther       Date:  2013-12-26       Impact factor: 11.454

Review 4.  A Historical Review of Brain Drug Delivery.

Authors:  William M Pardridge
Journal:  Pharmaceutics       Date:  2022-06-16       Impact factor: 6.525

Review 5.  Nanoparticle designs for delivery of nucleic acid therapeutics as brain cancer therapies.

Authors:  Johan Karlsson; Kathryn M Luly; Stephany Y Tzeng; Jordan J Green
Journal:  Adv Drug Deliv Rev       Date:  2021-10-27       Impact factor: 17.873

6.  Transport of human recombinant brain-derived neurotrophic factor (BDNF) through the rat blood-brain barrier in vivo using vector-mediated peptide drug delivery.

Authors:  W M Pardridge; Y S Kang; J L Buciak
Journal:  Pharm Res       Date:  1994-05       Impact factor: 4.200

Review 7.  Elimination of substances from the brain parenchyma: efflux via perivascular pathways and via the blood-brain barrier.

Authors:  Stephen B Hladky; Margery A Barrand
Journal:  Fluids Barriers CNS       Date:  2018-10-19

Review 8.  CNS delivery via adsorptive transcytosis.

Authors:  Françoise Hervé; Nicolae Ghinea; Jean-Michel Scherrmann
Journal:  AAPS J       Date:  2008-08-26       Impact factor: 4.009

9.  Immunocytochemical studies of protamine-induced blood-brain barrier opening to endogenous albumin.

Authors:  A W Vorbrodt; D H Dobrogowska; M Ueno; A S Lossinsky
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

Review 10.  Brain Delivery of Nanomedicines: Trojan Horse Liposomes for Plasmid DNA Gene Therapy of the Brain.

Authors:  William M Pardridge
Journal:  Front Med Technol       Date:  2020-11-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.